Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone

Fig. 6

Profile of protective efficacy of SMC against clinical malaria, among recipients of RTS,S/AS01E. Footnotes: Protective efficacy of SMC against clinical malaria over time, among children randomised to receive the RTS,S/AS01E malaria vaccine. Results are presented up to 30 days post-SMC (left panels), combining data from all 12 SMC cycles; and up to 60 days post-SMC (right panels), combining data from the final SMC cycle in each year of the study. The top panels show results from flexible parametric survival models, and the bottom panels show results from smoothed Schoenfeld residuals from Cox regression models

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us